Enhanced susceptibility of galectin-1 deficient mice to experimental colitis
dc.contributor.author | Fernández Pérez, Raquel | |
dc.contributor.author | López Santalla, Mercedes | |
dc.contributor.author | Sánchez Domínguez, Rebeca | |
dc.contributor.author | Alberquilla, Omaira | |
dc.contributor.author | Gutiérrez Cañas, Irene | |
dc.contributor.author | Juarranz Moratilla, Yasmina | |
dc.contributor.author | Bueren, Juan A. | |
dc.contributor.author | Garin, Marina I. | |
dc.date.accessioned | 2024-07-12T17:24:40Z | |
dc.date.available | 2024-07-12T17:24:40Z | |
dc.date.issued | 2021-06-28 | |
dc.description | Este trabajo fue subvencionado por el Instituto de Salud Carlos III y cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) | |
dc.description.abstract | Galectin-1 is a<jats:italic>β</jats:italic>-galactoside-binding lectin, ubiquitously expressed in stromal, epithelial, and different subsets of immune cells. Galectin-1 is the prototype member of the galectin family which shares specificity with<jats:italic>β</jats:italic>-galactoside containing proteins and lipids. Immunomodulatory functions have been ascribed to endogenous galectin-1 due to its induction of T cell apoptosis, inhibitory effects of neutrophils and T cell trafficking. Several studies have demonstrated that administration of recombinant galectin-1 suppressed experimental colitis by modulating adaptive immune responses altering the fate and phenotype of T cells. However, the role of endogenous galectin-1 in intestinal inflammation is poorly defined. In the present study, the well-characterized acute dextran sulfate sodium (DSS)-induced model of ulcerative colitis was used to study the function of endogenous galectin-1 during the development of intestinal inflammation. We found that galectin-1 deficient mice (<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice) displayed a more severe intestinal inflammation, characterized by significantly elevated clinical scores, than their wild type counterparts. The mechanisms underlying the enhanced inflammatory response in colitic<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice involved an altered Th17/Th1 profile of effector CD4<jats:sup>+</jats:sup>T cells. Furthermore, increased frequencies of Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells in colon lamina propria in<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice were found. Strikingly, the exacerbated intestinal inflammatory response observed in<jats:italic>Lgals1<jats:sup>−</jats:sup></jats:italic><jats:sup>/</jats:sup><jats:italic><jats:sup>−</jats:sup></jats:italic>mice was alleviated by adoptive transfer of wild type Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells at induction of colitis. Altogether, these data highlight the importance of endogenous galectin-1 as a novel determinant in regulating T cell reactivity during the development of intestinal inflammation. | |
dc.description.department | Depto. de Biología Celular | |
dc.description.faculty | Fac. de Ciencias Biológicas | |
dc.description.fundingtype | Pagado por el autor | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Ministerio de Ciencia, Innovación y Universidades (España) | |
dc.description.sponsorship | European Commission | |
dc.description.status | pub | |
dc.identifier.citation | Fernandez-Perez R, Lopez-Santalla M, Sánchez-Domínguez R, Alberquilla O, Gutiérrez-Cañas I, Juarranz Y, Bueren JA and Garin MI (2021) Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis. Front. Immunol. 12:687443. | |
dc.identifier.doi | 10.3389/fimmu.2021.687443 | |
dc.identifier.essn | 1664-3224 | |
dc.identifier.officialurl | https://doi.org/10.3389/fimmu.2021.687443 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/106065 | |
dc.journal.title | Frontiers in Immunology | |
dc.language.iso | eng | |
dc.page.final | 13 | |
dc.page.initial | 1 | |
dc.publisher | Frontiers Media | |
dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F00078/ES/MECANISMOS REGULADORES DE LA EXPRESION, SEÑALIZACION Y FUNCION DE LOS RECEPTORES VPAC PARA VALIDAR SU APLICACION CLINICA EN ENFERMEDADES INFLAMATORIAS%2FAUTOINMUNES/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F00027/ES/EJE VIP%2FRECEPTORES COMO BIOMARCADOR EN ENFERMEDADES REUMATICAS Y SU IMPLICACION EN LA DESTRUCCION DE CARTILAGO Y HUESO/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//RD16%2F0012%2F0008/ES/Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER)/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/MINECO//PIE15%2F00048/ES/mRNA ENGINEERED MESENCHYMAL STROMAL CELLS: A NEW GENERATION OF CELL THERAPY FOR INFLAMMATORY DISEASES/ | |
dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F01161/ES/TERAPIA CELULAR CON CELULAS MADRE MESENQUIMALES PARA EL TRATAMIENTO DE LA ARTRITIS REUMATOIDE/ | |
dc.rights | Attribution 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.cdu | 57.083 | |
dc.subject.cdu | 615.37 | |
dc.subject.cdu | 616.348-002 | |
dc.subject.keyword | Galectin-1 | |
dc.subject.keyword | Inflammatory bowel disease | |
dc.subject.keyword | Immune regulation | |
dc.subject.keyword | DSS | |
dc.subject.keyword | Cell therapy | |
dc.subject.keyword | Regulatory T cells | |
dc.subject.ucm | Inmunología | |
dc.subject.unesco | 3207.10 Inmunopatología | |
dc.title | Enhanced susceptibility of galectin-1 deficient mice to experimental colitis | |
dc.type | journal article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 12 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 20129605-5bb5-41f6-8dd8-32c0678ecb2f | |
relation.isAuthorOfPublication | 7e782adf-103d-4963-b9cf-ee711e7cb9db | |
relation.isAuthorOfPublication.latestForDiscovery | 20129605-5bb5-41f6-8dd8-32c0678ecb2f |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Enhanced_Susceptibility_Galectin-1.pdf
- Size:
- 3 MB
- Format:
- Adobe Portable Document Format